FibroBiologics News

Press Release: FibroBiologics Announces 2024 Annual Meeting of Stockholders

FibroBiologics Announces 2024 Annual Meeting of Stockholders HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company w

Dow JonesMay 15 16:30 ET

FibroBiologics 1Q Loss/Shr 27c >FBLG

FibroBiologics 1Q Loss/Shr 27c >FBLG

Dow JonesMay 14 17:26 ET

FibroBiologics | 10-Q: Quarterly report

SEC announcementMay 14 16:43 ET · Announcements

FibroBiologics to Present at the BIO International Convention 2024

HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of

GlobeNewswireMay 7 09:31 ET

FibroBiologics Files to Sell 1.8M Units

Seeking AlphaApr 26 15:23 ET

Express News | Fibrobiologics Files for Offering of up to 1.8 Mln Units, Each Consisting of One Common Share, One Warrant to Purchase One Common Share - SEC Filing

ReutersApr 26 06:08 ET

FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based sp

BenzingaApr 25 08:02 ET

Express News | Fibrobiologics Plans to Collaborate With Charles River to Manufacture Fibroblast-Based Spheroids

ReutersApr 25 08:00 ET

Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday

U.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday.Shares of Ally Financial Inc. (NYSE:ALLY) rose sharply during Thursday's session after the company reported better-

BenzingaApr 18 13:58 ET

Express News | Fibrobiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

Moomoo 24/7Apr 11 09:31 ET

FibroBiologics Presents Data From Dermal Fibroblast Spheroid-Based Treatment Of Chronic Wounds In A Diabetes Mouse Model At Advanced Wound Care Summit USA

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and potential cures for chronic

BenzingaApr 4 09:32 ET

Express News | FibroBiologics Files Patent Application Covering Fibroblast-Based Technology For Potential Lupus Treatment

Moomoo 24/7Mar 28 09:32 ET

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- FibroBiologics (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics

GlobeNewswireMar 28 09:31 ET

Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply

US stocks looked set to open flat Wednesday as investors awaited the Federal Reserve's decision on interest rates as the Federal Open Market Committee closes out its two-day meeting. Dow Jones Industr

MT NewswiresMar 20 09:14 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersEtao International Co (NASDAQ:ETAO) shares increased by 180.5% to $0.4 during Wednesday's pre-market session. The company's market cap stands at $40.4 million. Jaguar Health (NASDAQ:JAGX) stock

BenzingaMar 20 09:05 ET

Express News | FibroBiologics Shares Are Trading Higher After the Company Announced Preliminary Proof-of-concept for Fibroblast-based Diabetes Treatment

Moomoo 24/7Mar 19 14:51 ET

FibroBiologics Reports Encouraging Early Data for Diabetes Cell Therapy

Seeking AlphaMar 19 11:57 ET

FibroBiologics Announces Preliminary Proof Of Concept For Fibroblast-Based Diabetes Treatment

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures

BenzingaMar 19 09:33 ET

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

HOUSTON, March 19, 2024 /PRNewswire/ -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the develo

PR NewswireMar 19 09:31 ET

FibroBiologics to Present at Advanced Wound Care Summit USA

HOUSTON, March 13, 2024 /PRNewswire/ -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the develo

PR NewswireMar 13 09:31 ET